“…Sleep disturbance is one of the most common challenging symptoms for pediatric cancer patients, both during and following treatment. These issues often develop during the intense initial stages of chemotherapy treatment (Steur, Kaspers, et al, 2020), exacerbated by a hospital environment and medical procedures that are not conducive to good sleep (Fidler et al, 2022; Lee et al, 2017). For children with ALL whose chemotherapy treatment lasts for 2 to 3 years, their sleep often continues to suffer throughout therapy due to chemotherapy regimens that include pulsed administration of glucocorticoids (particularly dexamethasone) that are highly disruptive to children's sleep/wake patterns (Daniel, Li, et al, 2016; Hinds et al, 2007; Matthews et al, 2014; Rogers et al, 2014; Steur, Grootenhuis, et al, 2020).…”